This is a unique compilation, by experts worldwide, addressing how diabetes impacts the nervous system. For example, diabetic polyneuropathy, a disorder more common than MS, Parkinson's disease, and ALS combined, is a major source of disability to diabetic persons worldwide. This book addresses diabetic polyneuropathy and how diabetes alters other parts of the nervous system.
- Offers a unique emphasis on the neurological manifestations of diabetes
- Provides thorough coverage of the clinical, experimental, mechanistic, therapeutic, peripheral, and central aspects of diabetic neuropathy
- Edited work with chapters authored by leaders in the field around the globe - the broadest, most expert coverage available
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Section 1. CLINICAL IMPACT OF DIABETES ON THE NERVOUS SYSTEM 1. Epidemiology of polyneuropathy in diabetes and prediabetes 2. Clinical features of diabetic polyneuropathy 3. Focal and entrapment neuropathies 4. Diabetic radiculoplexus neuropathies 5. Painful diabetic neuropathy: clinical aspects 6. Diabetic autonomic neuropathy 7. Motor neuropathy 8. Diabetic neuropathy and foot ulceration 9. Glucose intolerance and neuropathy 10. Diabetic neuropathy in children 11. Cognitive disorders in diabetic patients 12. Stroke and diabetes mellitus 13. Neurological infections in diabetes mellitus 14. Recognition and management of psychosocial issues in diabetic neuropathy 15. Overview of diabetes management in patients with neurological disorders 16. Sexual dysfunction in diabetes
Section 2. DIAGNOSTIC AND THERAPEUTIC APPROACHES TO DIABETIC NEUROLOGICAL COMPLICATIONS 17. Electrophysiological testing in diabetic neuropathy 18. Diabetic neuropathy and nerve structure 19. Epidermal innervation in diabetes 20. Clinical and diagnostic features of small fibre damage in diabetic polyneuropathy 21. CNS imaging in cerebrovascular and white matter disease 22. Therapy for diabetic neuropathy: an overview 23. Methodology for conduct of epidemiologic surveys and randomized controlled trials of diabetic polyneuropathy
Section 3. FUNDAMENTAL STUDIES OF DIABETIC NEUROSCIENCE 24. Neuroscience of glucose homeostasis 25. Mechanisms of disease 1. Mitochondrial dysfunction in sensory neuropathy and other complications in diabetes 26. Mechanisms of diabetic neuron damage: molecular pathways 27. Mechanisms of diabetic neuropathy 3: Schwann cells 28. Mechanisms of disease: axon dysfunction 29. Mechanisms of disease: role of neurotrophins in diabetes and diabetic neuropathy 30. Experimental motor neuropathy in diabetes 31. Ischemic neuropathy 32. Diabetes and neurodegeneration in the brain 33. Neurological damage in hypoglycemia 34. Painful neuropathy-mechanisms 35. Insights into the pathogenesis and treatment of painful diabetic neuropathy 36. Autonomic neuropathy in experimental models of diabetes mellitus
Douglas Zochodne is a Professor with tenure at the University of Calgary in the Department of Clinical Neurosciences and the Hotchkiss Brain Institute. He trained in medicine and subsequently Neurology at the University of Western Ontario. He completed fellowships in Neuromuscular disease with Dr. Charles Bolton at Western and Drs. Phillip Low and Peter Dyck at Mayo Clinic. He served on faculty at Queen's University, Ontario Canada then subsequently at the University of Calgary where he has worked since 1992. He is a consultant Neurologist of Alberta Health Services, Calgary zone and serves as the Director of the Neuromuscular Clinic (Adult), University of Calgary and as Director of Clinical Neurophysiology (Adult EMG). Dr. Zochodne served as Editor-in-Chief of the Canadian Journal of Neurological Sciences from 1999-2007 and President of the Peripheral Nerve Society from 2009-2011. His research laboratory has been externally funded since 1988 by CIHR, CDA, JDRF, NIH and other agencies. He has published work focused on the peripheral neurobiology of regeneration, experimental diabetic neuropathy and clinical neuropathies and has authored over 240 original articles, chapters and books. He was awarded the Wolfe Prize in Neuropathy Research by the American Neurological Association in 2011. His more recent papers, published in the Journal of Neuroscience, Brain and Nature Communications, identifies roles for tumour suppressor proteins in enhancing adult neuron regeneration. He has recently accepted an offer to Chair the Division of Neurology at the University of Alberta and will be moving with his laboratory to take up this new role in July 2014.
Malik, Rayaz A.
Rayaz A. Malik is a Professor of Medicine at Weill Cornell Medical College, Qatar and Honorary Professor of Medicine and Consultant Physician in the Centre for Endocrinology and Diabetes, Central Manchester University Teaching Hospitals Foundation Trust and University of Manchester. He obtained his BSc., MSc. and MB ChB from the University of Aberdeen and his PhD from the University of Manchester. He is an expert in the pathogenesis, assessment and treatment of diabetic neuropathy and has been a co-editor for three books, co-authored over 30 book chapters and published (~130 peer reviewed papers) and presented (~500 national and international presentations) extensively. His research is funded by the NIH, JDRF, DUK, BHF and EU and his funding totals ~$8M. He was the Chairman of Neurodiab, the international study group of the EASD for Diabetic Neuropathy (2009-2012). He won the young clinical investigator prize for clinical science for Neurodiab in 1999, North West of England Medical Society Prize in 2000; North East Medical Society Prize 2012. He has been an invited lecturer for the American Diabetes Association 2003, 2007 and 2010, 2012, 2013; European Association for the Study of Diabetes 2004, 2007, 2008, 2010, 2012 and 2013 and World Diabetes Congress 2009, 2011, 2013. He is an associate editor for Diabetic Medicine (2006 to present); BMC Neurology (2009-present); Advances in Therapy (2009-present) and is on the editorial board for Journal of Diabetes and Its Complications (2012-present) and Journal of Diabetes Investigation (2012-present).